Allogene Therapeutics
Bianca Applebee is an experienced professional in sourcing and supplier management, currently serving as Associate Director at Allogene Therapeutics since June 2022, following the role of Senior Manager in the same department. Prior to Allogene, Bianca held the position of Procurement Manager at PACT Pharma and spent over six years at Genentech in various roles including US Chemicals Category Manager, Drug Product Process Engineering, and Supplier Quality positions. Bianca's career also includes experience as a Clinic Assistant at California Retina Consultants. Bianca earned a Graduate Certificate in Management of Technology and Engineering from Stanford University and a Bachelor of Science in Chemical Engineering from UC Santa Barbara.
This person is not in the org chart
Allogene Therapeutics
1 followers
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.